Morgan Stanley’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123K | Sell |
99,459
-77,520
| -44% | -$96.1K | ﹤0.01% | 6055 |
|
|
2025
Q1 | $216K | Sell |
176,979
-49,871
| -22% | -$60.8K | ﹤0.01% | 5700 |
|
|
2024
Q4 | $408K | Buy |
226,850
+148,669
| +190% | +$268K | ﹤0.01% | 5506 |
|
|
2024
Q3 | $398K | Buy |
78,181
+68,298
| +691% | +$348K | ﹤0.01% | 5505 |
|
|
2024
Q2 | $70.3K | Buy |
9,883
+8,174
| +478% | +$58.1K | ﹤0.01% | 6081 |
|
|
2024
Q1 | $4.68K | Sell |
1,709
-1,709
| -50% | -$4.68K | ﹤0.01% | 6907 |
|
|
2023
Q4 | $9.23K | Buy |
3,418
+1,709
| +100% | +$4.61K | ﹤0.01% | 6849 |
|
|
2023
Q3 | $4.5K | Hold |
1,709
| – | – | ﹤0.01% | 6938 |
|
|
2023
Q2 | $4.79K | Sell |
1,709
-60,607
| -97% | -$170K | ﹤0.01% | 6995 |
|
|
2023
Q1 | $181K | Buy |
62,316
+62,171
| +42,877% | +$180K | ﹤0.01% | 5751 |
|
|
2022
Q4 | $532 | Sell |
145
-4,622
| -97% | -$17K | ﹤0.01% | 7552 |
|
|
2022
Q3 | $15K | Sell |
4,767
-1,861
| -28% | -$5.86K | ﹤0.01% | 6931 |
|
|
2022
Q2 | $20K | Buy |
6,628
+946
| +17% | +$2.86K | ﹤0.01% | 6994 |
|
|
2022
Q1 | $47K | Sell |
5,682
-4,440
| -44% | -$36.7K | ﹤0.01% | 6740 |
|
|
2021
Q4 | $106K | Buy |
10,122
+4,009
| +66% | +$42K | ﹤0.01% | 6408 |
|
|
2021
Q3 | $110K | Buy |
+6,113
| New | +$110K | ﹤0.01% | 6312 |
|